These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 9643569

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical significance of minimal residual disease in childhood acute myeloid leukemia.
    Miyamura T, Sakata N, Okamura T, Yasui M, Inoue M, Yagi K, Sako M, Komada Y, Matsuyama T, Oda M, Park YD, Kawa K.
    Int J Hematol; 2004 Apr; 79(3):243-9. PubMed ID: 15168592
    [Abstract] [Full Text] [Related]

  • 5. Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay.
    Marcucci G, Livak KJ, Bi W, Strout MP, Bloomfield CD, Caligiuri MA.
    Leukemia; 1998 Sep; 12(9):1482-9. PubMed ID: 9737700
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears.
    Tsukamoto N, Karasawa M, Tanaka Y, Yokohama A, Uchiumi H, Matsushima T, Murakami H, Nojima Y.
    Int J Hematol; 2003 Nov; 78(4):362-9. PubMed ID: 14686496
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
    Kwong YL, Chan V, Wong KF, Chan TK.
    Cancer; 1995 Feb 01; 75(3):821-5. PubMed ID: 7828132
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia.
    Miyamoto T, Nagafuji K, Harada M, Eto T, Fujisaki T, Kubota A, Akashi K, Mizuno S, Takenaka K, Kanaji T.
    Br J Haematol; 1995 Sep 01; 91(1):132-8. PubMed ID: 7577620
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene.
    Meloni G, Diverio D, Vignetti M, Avvisati G, Capria S, Petti MC, Mandelli F, Lo Coco F.
    Blood; 1997 Aug 01; 90(3):1321-5. PubMed ID: 9242568
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is AML1/ETO gene expression a good prognostic factor in pediatric acute myeloblastic leukemia?
    Sarper N, Ozbek U, Ağaoğlu L, Ozgen U, Eryilmaz E, Yalman N, Anak S, Devecioğlu O, Gedikoğlu G.
    Pediatr Hematol Oncol; 2000 Aug 01; 17(7):577-83. PubMed ID: 11033733
    [Abstract] [Full Text] [Related]

  • 19. Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22).
    Zhang L, Li Q, Li W, Liu B, Wang Y, Lin D, Zhou C, Li C, Wang J, Mi Y.
    Int J Hematol; 2013 Jun 01; 97(6):786-92. PubMed ID: 23613269
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.